High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
Nicolas Villain, Vincent Planche, Richard Lévy
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.neurol.2022.06.012
- Published
- Sep 29, 2022
- Venue
- Revue Neurologique
- DOI
- 10.1016/j.neurol.2022.06.012
- PubMed
- 36184326
- Categories
- Alzheimer's disease research and treatments
- License
- cc-by-nc-nd
- Provenance
- openalex